Related Experiment Video
Updated: Jun 27, 2025

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Exosomal CircRNAs in Circulation Serve as Diagnostic Biomarkers for Acute Myocardial Infarction
Xiaoyan Liu1,2,3, Yeping Zhang1,2, Wen Yuan3
1Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chao-Yang Hospital, Capital Medical University, 100020 Beijing, China.
Insights
Circular RNAs (circRNAs) in exosomes show altered expression in acute myocardial infarction (AMI) patients. The circRNA hsa_circ_0001558 is a promising biomarker for diagnosing AMI, differentiating it from non-cardiogenic chest pain.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiovascular Research
Background:
- The diagnostic utility of exosomal circular RNAs (circRNAs) for acute myocardial infarction (AMI) remains underexplored.
- Existing research suggests a role for circRNAs in cardiovascular diseases.
Purpose of the Study:
- To investigate the diagnostic potential of exosomal circRNAs as biomarkers for AMI.
- To identify specific circRNAs that are differentially expressed in AMI patients.
Main Methods:
- High-throughput sequencing was used to identify differentially expressed circRNAs in exosomes from AMI patients.
- Real-Time polymerase chain reaction (RT-PCR) was employed to validate the expression of selected circRNAs.
- The study included 120 AMI patients and 83 patients with non-cardiogenic chest pain (NCCP).
Main Results:
- Sequencing revealed 893 differentially expressed exosomal circRNAs in AMI patients (118 up-regulated, 775 down-regulated).
- Three circRNAs (hsa_circ_0001558, hsa_circ_0001535, hsa_circ_0000972) were significantly up-regulated in AMI patients, with AUC values ranging from 0.683 to 0.79.
- hsa_circ_0001558 showed a 4.45-fold increase in AMI patients (AUC = 0.793), with higher expression in ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) compared to NCCP.
Conclusions:
- Significant differences in exosomal circRNA expression exist between AMI and NCCP patients.
- hsa_circ_0001558 is identified as a potential diagnostic biomarker for AMI.
- Further research is warranted to fully establish the clinical utility of exosomal circRNAs for AMI diagnosis.
Background:
The diagnostic potential of circular RNAs (circRNAs) in circulating exosomes for acute myocardial infarction (AMI) is not well understood, despite existing research indicating their role in cardiovascular diseases. This study aimed to clarify the significance of exosomal circular RNAs as indicators for AMI.
Methods:
We examined 120 individuals diagnosed with AMI and 83 individuals with non-cardiogenic chest pain (NCCP), all previously enrolled in a conducted study. High-throughput sequencing to identify differentially expressed circRNAs in the circulating exosomes of AMI patients. To validate, we employed Real-Time polymerase chain reaction (RT-PCR) targeting five circRNAs that exhibited notable increase.
Results:
The sequencing identified 893 exosomal circRNAs with altered expression in AMI patients, including 118 up-regulated and 775 down-regulated circRNAs. Genes linked to these circRNAs were enriched in crucial Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, highlighting their direct relevance to AMI pathophysiology. Three exosomal circRNAs (hsa_circ_0001558, hsa_circ_0001535, and hsa_circ_0000972) showed significant up-regulation in AMI patients during the initial validation cohort. The corresponding area under the curve (AUC) values were 0.79, 0.685, and 0.683, respectively. Further validation of hsa_circ_0001558 in a second cohort showed a 4.45-fold increase in AMI patients, with AUC = 0.793. The rise was particularly noticeable in patients with non-ST-elevation myocardial infarction (NSTEMI) (2.80 times, AUC = 0.72) and patients with ST-elevation myocardial infarction (STEMI) (5.27 times, AUC = 0.831) compared to patients with NCCP.
Conclusions:
Our findings demonstrate significant differences in the expression patterns of circRNAs in plasma exosomes between AMI patients and NCCP patients. Specifically, hsa_circ_0001558 appears as a promising indicator for AMI diagnosis. Further research is necessary to fully evaluate the diagnostic potential of exosomal circRNAs in the context of AMI, emphasizing the importance of these findings.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

